BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

  November 4, 2025

   · 

  2 min read
• Press Releases

  Remix Therapeutics to Present at Guggenheim Second Annual Healthcare Innovation Conference

  November 4, 2025

   · 

  1 min read
• Press Releases

  Recludix Pharma to Present at Two Investor Conferences in November 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Avalyn to Participate in Multiple Upcoming Investor Conferences in November 2025

  November 4, 2025

   · 

  2 min read
• Press Releases

  Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

  November 4, 2025

   · 

  9 min read
• Press Releases

  BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025

  November 4, 2025

   · 

  3 min read
• Press Releases

  Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

  November 4, 2025

   · 

  7 min read
• Press Releases

  Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors

  November 4, 2025

   · 

  3 min read
• Press Releases

  Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

  November 4, 2025

   · 

  4 min read
• Press Releases

  Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

  November 4, 2025

   · 

  4 min read